Social Anxiety Disorder Responds to Vistagen’s Nasal Spray in Phase 3 Trial

Vistagen’s fasedienol (PH94B) nasal spray for social anxiety disorder (SAD) showed a statistically significant reduction in anxiety measures during a public speaking challenge, using a measure of subjective units of stress score.
Source: Drug Industry Daily

Leave a Reply